Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
Aarti Pharmalabs
|
FDC
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | n/a | 2.22 % |
|
Financials
|
|||
|
5 yr Average ROE
|
-0.59 % | 9.05 % | 12.9 % |
|
5yr average Equity Multiplier
|
3.58 | 1.39 | 1.57 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.58 | 0.55 |
|
5yr Avg Net Profit Margin
|
1.67 % | 8.95 % | 15.2 % |
|
Price to Book
|
2.27 | 3.94 | 2.77 |
|
P/E
|
20.22 | 29.4 | 29.87 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | 94.46 Days | -13.89 Days |
|
Inventory Days
|
60.56 Days | 94.9 Days | 61.89 Days |
|
Days Receivable
|
71.09 Days | 94.46 Days | 18.98 Days |
|
Days Payable
|
82.93 Days | 76.47 Days | 89.17 Days |
|
5yr Average Interest Coverage Ratio
|
6.25 | 12.05 | 90.41 |
|
5yr Avg ROCE
|
6.7 % | 12.13 % | 13.8 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 15.5 % | 17.7 % |
|
5 yr average Debt to Equity
|
0.43 | 0.16 | 0.0 |
|
5yr CAGR Net Profit
|
22.48 % | n/a | -2.41 % |
|
5yr Average Return on Assets
|
1.78 % | 6.11 % | 8.22 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 42.88 % | 69.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.01 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -3.1 % | 0.17 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.26 % | -4.32 % | 0.03 % |
|
Akums Drugs & Pharma
|
Aarti Pharmalabs
|
FDC
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|